Robert C Bruce Net Worth

The estimated Net Worth of Robert C Bruce is at least $3.79 Thousand dollars as of 30 November 2007. Robert Bruce owns over 1,000 units of Immucell stock worth over $3,790 and over the last 17 years Robert sold ICCC stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Robert Bruce ICCC stock SEC Form 4 insiders trading

Robert has made over 1 trades of the Immucell stock since 2007, according to the Form 4 filled with the SEC. Most recently Robert bought 1,000 units of ICCC stock worth $4,000 on 30 November 2007.

The largest trade Robert's ever made was buying 1,000 units of Immucell stock on 30 November 2007 worth over $4,000. On average, Robert trades about 1,000 units every 0 days since 2007. As of 30 November 2007 Robert still owns at least 1,000 units of Immucell stock.

You can see the complete history of Robert Bruce stock trades at the bottom of the page.

What's Robert Bruce's mailing address?

Robert's mailing address filed with the SEC is Danyang, Zhenjiang, Jiangsu, China, 212312.

Insiders trading at Immucell

Over the last 21 years, insiders at Immucell have traded over $168,227 worth of Immucell stock and bought 568,684 units worth $2,330,117 . The most active insiders traders include Jonathan E Rothschild, Norman H Pessin, and Joseph H Crabb. On average, Immucell executives and independent directors trade stock every 50 days with the average trade being worth of $22,979. The most recent stock trade was executed by David Cunningham on 13 June 2022, trading 1,000 units of ICCC stock currently worth $8,000.

What does Immucell do?

immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.

Complete history of Robert Bruce stock trades at Immucell

Immucell executives and stock owners

Immucell executives and other stock owners filed with the SEC include:

• Michael F. Brigham,
  Pres, CEO, Principal Financial Officer, Treasurer, Sec. & Director
• Michael Brigham,
  President, Chief Executive Officer, Treasurer, Secretary, Director
• Bobbi Brockmann,
  Vice President - Sales and Marketing, Director
• Elizabeth Williams,
  Vice President - Manufacturing Operations
• Elizabeth L. Williams,
  VP of Manufacturing Operations
• Dr. Joseph H. Crabb Ph.D.,
  VP & Chief Scientific Officer
• Joseph Crabb,
  Chief Scientific Officer, Vice President
• David Tomsche,
  Chairman of the Board
• Paul Wainman,
  Independent Director
• Jonathan Rothschild,
  Independent Director
• Steven Rosgen,
  Independent Director
• David Cunningham,
  Independent Director
• John W. Zinckgraf,
  Director of Product Devel.
• A. Gustavo Scaffa,
  Sr. Director of Quality
• Elizabeth S. Toothaker,
  Director of Fin. & Admin.
• Linda Rhodes,
  Director
• Brian L. Pessin,
  
• Norman H Pessin,
  
• Gloria F Basse,
  Director
• Anthony B Cashen,
  Director
• Robert C Bruce,
  Director
• William H Maxwell,
  Director
• Bryan K. Gathagan,